ASAN FOUNDATION
π°π·South Korea
- Country
- π°π·South Korea
- Ownership
- Private
- Established
- 1989-06-23
- Employees
- 501
- Market Cap
- -
- Website
- https://ails.amc.seoul.kr
Impact of Dexmedetomidine on Acute Kidney Injury Following Living Donor Liver Transplantation
Phase 4
Active, not recruiting
- Conditions
- Acute Kidney InjuryLiver Diseases
- Interventions
- Drug: Normal salineDrug: Dexmedetomidine
- First Posted Date
- 2018-05-11
- Last Posted Date
- 2023-07-17
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 214
- Registration Number
- NCT03522688
- Locations
- π°π·
Asan medical center, Seoul, Songpa-gu, Korea, Republic of
The Size of Pelvic Hematoma Can be a Predictive Factor for Angioembolization
Completed
- Conditions
- Multiple Pelvic Fractures
- First Posted Date
- 2018-05-09
- Last Posted Date
- 2018-05-09
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 46
- Registration Number
- NCT03519594
Evaluation of [18F]PI-2620 as a Potential Positron Emission Computed Tomography Radioligand for Imaging Tau Protein in the Brain
Early Phase 1
Completed
- Conditions
- Healthy VolunteerFrontotemporal DementiaAlzheimer DiseaseParkinson Disease
- Interventions
- Drug: [18F]PI-2620
- First Posted Date
- 2018-04-27
- Last Posted Date
- 2020-12-14
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 20
- Registration Number
- NCT03510572
- Locations
- π°π·
Asan Medical Center, Seoul, Korea, Republic of
Reversible Cerebral Vasoconstriction Syndrome and Varicella Zoster Virus
- Conditions
- Varicella-zoster Virus InfectionReversible Cerebral Vasoconstriction Syndrome
- Interventions
- Diagnostic Test: VZV-specific antibody response from blood
- First Posted Date
- 2018-04-26
- Last Posted Date
- 2018-08-29
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 40
- Registration Number
- NCT03509701
- Locations
- π°π·
Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of
A Prospective Randomized Comparison of HDAC vs AD in the Induction Chemothrapy for AML.
Phase 3
- Conditions
- Acute Myeloid Leukemia
- Interventions
- First Posted Date
- 2018-04-25
- Last Posted Date
- 2020-01-13
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 380
- Registration Number
- NCT03507842
- Locations
- π°π·
Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of
Urinary Transglutaminase 2 as a Biomarker for Kidney Allograft Fibrosis
- Conditions
- Kidney Allograft FibrosisKidney Transplant Failure and Rejection
- First Posted Date
- 2018-04-04
- Last Posted Date
- 2018-04-04
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 1000
- Registration Number
- NCT03487861
- Locations
- π°π·
Asan Medical Center, Seoul, Korea, Republic of
Management of Imatinib-associated Severe Skin Rash in Patients With Gastrointestinal Stromal Tumor
- First Posted Date
- 2018-02-22
- Last Posted Date
- 2020-01-07
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 29
- Registration Number
- NCT03440515
Durvalumab for MSI-H or POLE Mutated Metastatic Colorectal Cancer
- First Posted Date
- 2018-02-15
- Last Posted Date
- 2024-10-14
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 33
- Registration Number
- NCT03435107
- Locations
- π°π·
Asan Medical Center, Seoul, Korea, Republic of
Evaluate Efficacy of Respiratory Rehabilitation Personalized Mobile Services for Respiratory Diseases
Not Applicable
Completed
- Conditions
- Lung CancerRespiratory DiseaseCOPD
- Interventions
- Other: Fixed respiratory rehabilitationOther: Responsive respiratory rehabilitation
- First Posted Date
- 2018-02-14
- Last Posted Date
- 2018-02-28
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 179
- Registration Number
- NCT03432117
- Locations
- π°π·
Asan Medical Center, Seoul, Korea, Republic of
π°π·Wonju Severance Christian Hospital, Wonju, Gangwon-do, Korea, Republic of
π°π·Smg-Snu Boramae Medical Center, Seoul, Korea, Republic of
L-carnitine vs Placebo for the Treatment of Muscle Cramps After Imatinib in Gastrointestinal Stromal Tumors
Phase 3
Completed
- Conditions
- Gastrointestinal Stromal Tumors (GISTs)
- Interventions
- Drug: L-carnitineDrug: Placebo
- First Posted Date
- 2018-02-08
- Last Posted Date
- 2020-07-13
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 4
- Registration Number
- NCT03426722
- Locations
- π°π·
Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of
Β© Copyright 2025. All Rights Reserved by MedPath